Anna Nowak
Anna Nowak
Verified email at meddent.uwa.edu.au - Homepage
TitleCited byYear
The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer
P Goldstraw, K Chansky, J Crowley, R Rami-Porta, H Asamura, ...
Journal of Thoracic Oncology 11 (1), 39-51, 2016
9192016
Mesothelin-family proteins and diagnosis of mesothelioma
BWS Robinson, J Creaney, R Lake, A Nowak, AW Musk, N de Klerk, ...
The Lancet 362 (9396), 1612-1616, 2003
5722003
Modified RECIST criteria for assessment of response in malignant pleural mesothelioma
MJ Byrne, AK Nowak
Annals of Oncology 15 (2), 257-260, 2004
5272004
Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells
AK Nowak, RA Lake, AL Marzo, B Scott, WR Heath, EJ Collins, ...
The Journal of Immunology 170 (10), 4905-4913, 2003
4132003
Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors
AK Nowak, BWS Robinson, RA Lake
Cancer research 63 (15), 4490-4496, 2003
4032003
A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma
AK Nowak, MJ Byrne, R Williamson, G Ryan, A Segal, D Fielding, ...
British journal of cancer 87 (5), 491, 2002
2452002
Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy
AK Nowak, BWS Robinson, RA Lake
Cancer research 62 (8), 2353-2358, 2002
2332002
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
M Weller, N Butowski, DD Tran, LD Recht, M Lim, H Hirte, L Ashby, ...
The Lancet Oncology 18 (10), 1373-1385, 2017
2162017
The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth …
WD Travis, H Asamura, AA Bankier, MB Beasley, F Detterbeck, DB Flieder, ...
Journal of Thoracic Oncology 11 (8), 1204-1223, 2016
2102016
Systemic therapy for advanced hepatocellular carcinoma: a review
AK Nowak, PKH Chow, M Findlay
European journal of cancer 40 (10), 1474-1484, 2004
1922004
Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG …
RJ Francis, MJ Byrne, AA Van Der Schaaf, JA Boucek, AK Nowak, ...
Journal of Nuclear Medicine 48 (9), 1449-1458, 2007
1862007
Taxanes for adjuvant treatment of early breast cancer
T Ferguson, N Wilcken, R Vagg, D Ghersi, AK Nowak
Cochrane database of systematic reviews, 2007
1752007
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma
N van Zandwijk, C Clarke, D Henderson, AW Musk, K Fong, A Nowak, ...
Journal of thoracic disease 5 (6), E254, 2013
1672013
New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents
AK Nowak, RA Lake, HL Kindler, BWS Robinson
Seminars in oncology 29 (1), 82-96, 2002
1562002
Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial
MR Stockler, R O'Connell, AK Nowak, D Goldstein, J Turner, ...
The lancet oncology 8 (7), 603-612, 2007
1322007
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3 …
MJ van den Bent, B Baumert, SC Erridge, MA Vogelbaum, AK Nowak, ...
The Lancet 390 (10103), 1645-1653, 2017
1282017
Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled …
M Maio, A Scherpereel, L Calabṛ, J Aerts, SC Perez, A Bearz, ...
The Lancet Oncology 18 (9), 1261-1273, 2017
1282017
Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target
M Jackson, F Hassiotou, A Nowak
Carcinogenesis 36 (2), 177-185, 2014
1272014
Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide
G Dresemann, M Weller, MA Rosenthal, U Wedding, W Wagner, E Engel, ...
Journal of neuro-oncology 96 (3), 393-402, 2010
1192010
Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer
MR Stockler, VJ Harvey, PA Francis, MJ Byrne, SP Ackland, B Fitzharris, ...
J Clin Oncol 29 (34), 4498-4504, 2011
1152011
The system can't perform the operation now. Try again later.
Articles 1–20